US · Healthcare

23andMe Holding Co. (MEHCQ)

Diagnostics & Research

23andMe Holding Co. (MEHCQ) is listed on US in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for MEHCQ

P/E ratio

18.00

23andMe Holding Co. (MEHCQ) — FAQ

What is MEHCQ's P/E ratio?

The price-to-earnings (P/E) ratio for 23andMe Holding Co. (MEHCQ) is 18.00 (data as of 2026-05-23).

Does 23andMe Holding Co. pay a dividend?

Dividend yield is not available in the current snapshot for 23andMe Holding Co. (MEHCQ). Check the MyAverix Finance app for the latest dividend data.

What sector is 23andMe Holding Co. in?

23andMe Holding Co. (MEHCQ) is classified in the Healthcare sector (Diagnostics & Research industry).

What exchange is MEHCQ listed on?

MEHCQ is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)